Abstract
Green analytical chemistry is concerned with making analytical techniques more secure and environmentally friendly. A crucial aspect of this approach is the assessment of the greenness of analytical methods. Remdesivir, a SARS-CoV-2 nucleotide analog RNA polymerase inhibitor, has been authorized by USFDA as the initial course of therapy for hospitalized COVID-19 patients. The proposed study evaluates greenness of several reported chromatographic methods for estimation of Remdesivir using seven different tools namely ComplexGAPI, BAGI, AGREE, AGREEprep, AMGS, ChlorTox and RGBfast.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
